Docbot Announces Results of Study Evaluating Deep Learning Platform for Ulcerative Colitis Published in Journal, Gastroenterology
PRNewswire/ -- Docbot, Inc., a privately-held company developing leading artificial intelligence (AI)-driven healthcare applications, today announced results from a study evaluating machine reading using Docbot’s investigational deep learning AI platform (“Ultivision*”) for automated disease activity scoring in patients with ulcerative colitis.
PRNewswire/ -- Docbot, Inc., a privately-held company developing leading artificial intelligence (AI)-driven healthcare applications, today announced results from a study evaluating machine reading using Docbot’s investigational deep learning AI platform (“Ultivision*”) for automated disease activity scoring in patients with ulcerative colitis.
driven healthcare applications, leading artificial intelligence, results, automated disease activity scoring, Ultivision, machine, patients, Docbot’s investigational deep learning AI platform, ulcerative colitis, study, Company, PRNewswire
